A carregar...
Latest Evidence on Sulfonylureas: What’s New?
This review addresses the question of the cardiovascular (CV) safety of sulfonylureas (SUs) in patients with type 2 diabetes mellitus (T2DM) when directly tested against comparator agents in CV outcome trials. Presented at a recent symposium entitled “SUs in the treatment of T2DM: a fresh look and n...
Na minha lista:
| Publicado no: | Diabetes Ther |
|---|---|
| Autor principal: | |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Springer Healthcare
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7261305/ https://ncbi.nlm.nih.gov/pubmed/32323156 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s13300-020-00812-2 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|